Advertisement
Screener

Humacyte, Inc. (HUMA) Employee Count

Humacyte, Inc. Employee Count

The employee counts Humacyte, Inc. states in its annual reports on SEC EDGAR, each as filed.

  • 2025-12-31: Employees (as filed) 184; Filing 2026-03-27; Lease expense per employee $20,217.39.
  • 2024-12-31: Employees (as filed) 220; Filing 2025-03-31; Lease expense per employee $16,881.82.
  • 2023-12-31: Employees (as filed) 185; Filing 2024-03-28; Lease expense per employee $20,940.54.
  • 2022-12-31: Employees (as filed) 164; Filing 2023-03-24; Lease expense per employee $24,701.22.
Available history
2021-12-31 to 2025-12-31

Historical Employee Count

DateEmployees (as filed)FilingLease expense per employee
2025-12-31184
full-time
2026-03-27$20,217.39
total lease cost
2024-12-31220
full-time
2025-03-31$16,881.82
total lease cost
2023-12-31185
full-time
2024-03-28$20,940.54
total lease cost
2022-12-31164
full-time
2023-03-24$24,701.22
total lease cost
2021-12-31146
full-time
2022-03-29$28,828.77
total lease cost

Similar stocks

Stock NameCountryMarket CapPE Ratio
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63